Related Experiment Video
Updated: Jul 13, 2026

09:38
Identification of Nucleolar Factors During HIV-1 Replication Through Rev Immunoprecipitation and Mass Spectrometry
Published on: June 26, 2019
8.2K
P4PP: A Universal Shotgun Proteomics Data Analysis Pipeline for Virus Identification
Armand Paauw1, Evgeni Levin2, Ingrid A I Voskamp-Visser1
1Department of CBRN Protection, Netherlands Organization for Applied Scientific Research TNO, TNO, Rijswijk, the Netherlands.
Molecular & Cellular Proteomics : MCP
|May 31, 2025
Summary
A new proteomic data analysis pipeline (P4PP) identifies 1896 virus species, including human infectious viruses. This method enhances viral diagnostics for emerging and mutated viruses.
Area of Science:
- Virology
- Proteomics
- Bioinformatics
Background:
- Human viral infections pose a significant threat, necessitating advanced detection methods.
- Existing diagnostic tools may struggle with novel, mutated, or re-emerging viral threats.
Purpose of the Study:
- To develop and validate a data analysis approach for shotgun proteomic data to detect diverse virus species.
- To establish a comprehensive proteome database and pipeline for pandemic preparedness (P4PP).
Main Methods:
- Development of the P4PP pipeline and database (P4PP v01) for virus identification.
- Analysis of 174 mass spectrometry datasets from virus-infected and non-infected cell lines.
- Utilized discriminatory peptides for species-level virus identification.
Main Results:
- The P4PP pipeline successfully identified 1896 virus species across 32 families.
- 146 out of 160 virus-infected samples were correctly identified at the species level; 4 at the family level.
- Accurate subtyping of influenza A and SARS-CoV-2 was demonstrated with sufficient peptide data.
Conclusions:
- Shotgun proteomics combined with the P4PP approach can identify all virus types cultivated in cell lines.
- This agnostic virus proteome analysis has the potential to significantly enhance viral diagnostic laboratories' capabilities.
- The P4PP system offers improved preparedness against unexpected, mutated, or re-emerging viral pathogens.

